# OnCo record nct05415072 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05415072/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05415072", "NCT05415072" ;
  schema:name "A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas"@en ;
  schema:description "A phase 1/2 trial of DYP688 in uveal melanoma, run by Novartis Pharmaceuticals, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05415072/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05415072> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2022-07-04" ;
  onco:cancers <https://onco.cc/cancers/uveal-melanoma/> ;
  onco:companies <https://onco.cc/companies/novartis/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nct05415072-nat-med-2026/> .